3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Neutropenia
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myeloid, Acute
3
Febrile Neutropenia
3
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Intraocular Lymphoma
2
Infections
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Urinary Tract Infections
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Stem Cell Transplant Complications
1
Interventions
Dutasteride
3
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
proxalutamide
1
polyphenon E
1
mirabegron
1
TroVax
1
Transurethral Resection of Prostate
1
Transurethral Resection of Bladder
1
Therapeutics
1
Tamsulosin
1
Standard of Care
1
Risedronic Acid
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Prostatectomy
1
Papaverine
1
Oxygen
1
Nitrous Oxide
1
Needles
1
Microspheres
1
Lycopene
1
Levofloxacin
1
Finasteride
1
Electroacupuncture
1
Doxazosin
1
Docetaxel
1
Diclofenac
1
Dexmedetomidine
1
Cystoscopy
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Prostatic Hyperplasia
×
Levofloxacin
×
Clear all
NCT04212403
2020-02-24
Prophylaxis001
Jessa Hospital
Phase NA
Completed
1,350 enrolled